Skip to main content

Table 3 Cox regression analysis of overall survival in LUAD patients

From: EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma

Variables

Univariate analysis

Multivariate analysis

HR

95% CI

P value

HR

95% CI

P value

Age (years)

(≤ 60 vs > 60)

1.180

0.529–2.629

0.686

   

Gender

(male vs female)

0.949

0.419–2.150

0.900

   

pT stage

1.489

0.898–2.469

0.123

   

pN stage

3.162

1.435–6.965

0.004*

1.336

0.479–3.725

0.580

pTNM stage

2.583

1.505–4.432

 <0.001*

1.530

0.738–3.173

0.253

EFNA3 expression

4.272

1.597–11.423

0.004*

3.108

1.077–8.963

0.036*

  1. Factors for which P < 0.05 in univariate analysis were subsequently used for multivariate analysis
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us